Corcept Therapeutics (CORT) returns
Corcept Therapeutics returns over 10 years
$1,000 invested in Corcept Therapeutics ten years ago was worth $11,740 at the close on October 30, 2026, with dividends reinvested: an average return of 27.9% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -29.6% | — | $703.98 | -0.9% |
| 3 months | -31.4% | — | $685.60 | +2.1% |
| Year to date | +133.1% | — | $2,331 | +11.7% |
| 1 year | +12.3% | — | $1,123 | +12.4% |
| 3 years | +196.8% | +43.7% | $2,968 | +88.5% |
| 5 years | +350.7% | +35.1% | $4,507 | +76.0% |
| 10 years | +1,074% | +27.9% | $11,740 | +316.6% |
Corcept Therapeutics return by calendar year
| Year | CORT | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +133.1% | +11.7% | +121.4% |
| 2025 | -30.9% | +17.7% | -48.7% |
| 2024 | +55.1% | +24.9% | +30.3% |
| 2023 | +59.9% | +26.2% | +33.7% |
| 2022 | +2.6% | -18.2% | +20.7% |
| 2021 | -24.3% | +28.7% | -53.1% |
| 2020 | +116.2% | +18.4% | +97.8% |
| 2019 | -9.4% | +31.2% | -40.7% |
| 2018 | -26.0% | -4.6% | -21.5% |
| 2017 | +148.8% | +21.7% | +127.1% |
| 2016 | +45.8% | +12.0% | +33.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: CORT financials · CORT valuation
No forecast, no recommendation. This page describes Corcept Therapeutics from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.